Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q2 2018 (← Previous) (Next →)

Filing Date: Aug 14, 2018

Total Value: $340M (100.0% shares, 0.0% debt)

Holdings (46)

IMMUNOMEDICS INC 8.7%
Value $29.59M Shares 1,250,000 Est. Cost $8.35 Unrealized
MIRATI THERAPEUTICS INC 7.3%
Value $24.65M Shares 500,000 Est. Cost $33.00 Unrealized
SRPT SAREPTA THERAPEUTICS INC 6.8%
Value $23.13M Shares 175,000 Est. Cost $66.68 Unrealized +41.4%
PTCT PTC THERAPEUTICS INC 6.7%
Value $22.77M Shares 675,000 Est. Cost $29.45 Unrealized +5.9%
ALNY ALNYLAM PHARMACEUTICALS INC 6.1%
Value $20.68M Shares 210,000 Est. Cost $99.19 Unrealized 0.0%
BLUEBIRD BIO INC 4.9%
Value $16.48M Shares 105,000 Est. Cost $156.95 Unrealized
ARGX ARGENX SE 3.7%
Value $12.43M Shares 150,000 Est. Cost $21.52 Unrealized
ASND ASCENDIS PHARMA A S 3.4%
Value $11.64M Shares 175,000 Est. Cost $42.91 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 3.2%
Value $10.94M Shares 242,000 Est. Cost $45.20 Unrealized
MERSANA THERAPEUTICS INC 3.2%
Value $10.72M Shares 600,000 Est. Cost $16.89 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS IN 2.8%
Value $9.52M Shares 700,000 Est. Cost $6.16 Unrealized +51.8%
ASSEMBLY BIOSCIENCES INC 2.7%
Value $9.214M Shares 235,000 Est. Cost $45.55 Unrealized
EXEL EXELIXIS INC 2.5%
Value $8.608M Shares 400,000 Est. Cost $20.68 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 2.4%
Value $8.169M Shares 535,000 Est. Cost $25.20 Unrealized -29.2%
DICERNA PHARMACEUTICALS INC 2.4%
Value $8.085M Shares 660,000 Est. Cost $9.28 Unrealized
ADAMAS PHARMACEUTICALS INC 2.2%
Value $7.62M Shares 295,000 Est. Cost $23.90 Unrealized
KADMON HLDGS INC 2.2%
Value $7.581M Shares 1,900,000 Est. Cost $3.88 Unrealized
ENDOCYTE INC 2.0%
Value $6.9M Shares 500,000 Est. Cost $9.09 Unrealized
RCKT ROCKET PHARMACEUTICALS INC 2.0%
Value $6.871M Shares 350,000 Est. Cost $16.31 Unrealized +16.0%
MDGL MADRIGAL PHARMACEUTICALS INC 1.9%
Value $6.573M Shares 23,500 Est. Cost $175.60 Unrealized 0.0%
AVROBIO INC 1.9%
Value $6.569M Shares 230,000 Est. Cost $28.56 Unrealized
GLYCOMIMETICS INC 1.9%
Value $6.452M Shares 400,000 Est. Cost $16.19 Unrealized
VRAYQ VIEWRAY INC 1.8%
Value $6.228M Shares 900,000 Est. Cost $6.99 Unrealized +4.0%
OBSEVA SA 1.8%
Value $6.056M Shares 400,000 Est. Cost $9.76 Unrealized
TRICIDA INC 1.6%
Value $5.562M Shares 186,019 Est. Cost $29.90 Unrealized
AUDENTES THERAPEUTICS INC 1.4%
Value $4.776M Shares 125,000 Est. Cost $38.21 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 1.4%
Value $4.608M Shares 360,000 Est. Cost $15.14 Unrealized -3.5%
KURA KURA ONCOLOGY INC 1.2%
Value $4.186M Shares 230,000 Est. Cost $16.94 Unrealized 0.0%
BIODELIVERY SCIENCES INTL IN 1.2%
Value $4.163M Shares 1,411,247 Est. Cost $2.95 Unrealized
CATALYST BIOSCIENCES INC 1.2%
Value $4.143M Shares 355,000 Est. Cost $25.80 Unrealized
APLS APELLIS PHARMACEUTICALS INC 1.2%
Value $4.07M Shares 185,000 Est. Cost $22.98 Unrealized 0.0%
NEOS THERAPEUTICS INC 1.1%
Value $3.75M Shares 600,000 Est. Cost $7.80 Unrealized
LANNET INC 1.0%
Value $3.4M Shares 250,000 Est. Cost $16.05 Unrealized
GENOCEA BIOSCIENCES INC 0.9%
Value $3.016M Shares 3,525,000 Est. Cost $0.86 Unrealized
AVADEL PHARMACEUTICALS PLC 0.8%
Value $2.759M Shares 450,000 Est. Cost $7.29 Unrealized
ANAB ANAPTYSBIO INC 0.3%
Value $1.115M Shares 15,700 Est. Cost $100.41 Unrealized -16.5%
ZAFGEN INC 0.3%
Value $1.046M Shares 102,263 Est. Cost $10.23 Unrealized
ACORDA THERAPEUTICS INC 0.3%
Value $947K Shares 33,000 Est. Cost $28.70 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 0.2%
Value $828K Shares 14,000 Est. Cost $57.95 Unrealized 0.0%
EDGE THERAPEUTICS INC 0.2%
Value $773K Shares 750,792 Est. Cost $1.03 Unrealized
MOTUS GI HLDGS INC 0.2%
Value $719K Shares 100,000 Est. Cost $4.48 Unrealized
TGTX TG THERAPEUTICS INC 0.2%
Value $684K Shares 52,000 Est. Cost $12.78 Unrealized +7.6%
SPECTRUM PHARMACEUTICALS INC 0.2%
Value $608K Shares 29,000 Est. Cost $20.97 Unrealized
XBI SPDR SERIES TRUST 0.2%
Value $525K Shares 5,000 Est. Cost Unrealized
LANNET INC 0.2%
Value $520K Shares 2,000 Est. Cost $16.05 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 0.0%
Value $122K Shares 2,000 Est. Cost $26.17 Unrealized